PMID: 7543608Sep 1, 1995Paper

Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer

The Journal of Urology
S E LernerHorst Zincke

Abstract

A positive post-irradiation prostatic biopsy associated with an increasing prostate specific antigen level but no palpable evidence of local progression may identify a subgroup of patients who could be cured by salvage surgical therapy. Between 1967 and 1992, 132 patients underwent salvage surgery, including radical retropubic prostatectomy in 79, anterior exenteration in 38, total exenteration in 5 and bilateral pelvic lymphadenectomy only in 10. The 10-year cancer-specific survival rate in the prostatectomy group was 72%. Local control was equivalent among the surgical groups. Radical retropubic prostatectomy patients with negative surgical margins and nonaneuploid tumors demonstrated a significant survival advantage. Adjuvant hormonal therapy improved the disease-free survival rate in patients with nonaneuploid tumors. Radical retropubic prostatectomy can achieve excellent survival with low morbidity in select patients. Patients with clinical stage T2 or less disease and with prostate specific antigen detected cancers (52% and 75%, respectively) had pathological stage T2 disease. Thus, by using modern diagnostic techniques patients can be identified who may be cured with salvage surgery.

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·D A KubanP Schellhammer
Jun 1, 1988·Cancer Metastasis Reviews·A BomirskiJ Bigda
Nov 20, 1987·JAMA : the Journal of the American Medical Association
Apr 1, 1988·Cancer·I M ThompsonF R Rodriguez
Jan 1, 1994·International Journal of Radiation Oncology, Biology, Physics·R S CoxM A Bagshaw
Feb 1, 1993·Cancer·J E PontesR Huben

❮ Previous
Next ❯

Citations

Dec 10, 1998·Journal of Surgical Oncology·M V TefilliJ E Pontes
Jun 8, 2012·Der Urologe. Ausg. A·T FranzJ-U Stolzenburg
Nov 26, 2010·World Journal of Urology·Stephen B Williams, Jim C Hu
Sep 3, 2004·Current Treatment Options in Oncology·Andrew J StephensonJames A Eastham
Apr 2, 2003·Urology·Douglas ScherrUNKNOWN National Comprehensive Cancer Network
Feb 23, 1999·The Urologic Clinics of North America·D K OrnsteinG L Andriole
Sep 10, 2003·Current Problems in Cancer·Judd W Moul
Mar 3, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C C Parker, D P Dearnaley
Dec 7, 2002·Ultrasound in Medicine & Biology·A E WorthingtonM D Sherar
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Jonathan I IzawaLouis L Pisters
Oct 8, 2003·International Journal of Radiation Oncology, Biology, Physics·John A KalapurakalVythialingam Sathiaseelan
Jul 15, 1997·International Journal of Radiation Oncology, Biology, Physics·C I SartorH M Sandler
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·S NagY Yu
Jan 19, 2010·Journal of Endourology·Seth A StropeBrent K Hollenbeck
May 18, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P PaparelUNKNOWN membres du sous-comité prostate du CCAFU
Dec 24, 2015·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Stefano ArcangeliVittorio Donato
Nov 2, 2015·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L SalomonM Soulié
May 21, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Costantino LeonardoMichele Gallucci
Nov 4, 2000·The Journal of Urology·A Vaidya, M S Soloway
Jul 20, 1999·The Journal of Urology·P PerrotteL L Pisters
Dec 19, 2003·The Urologic Clinics of North America·Charles CattonMary Gospodarowicz
Jun 17, 2016·Future Oncology·Kevin C McCammackDaniel Ja Margolis
May 19, 2010·The Journal of Urology·Geoffrey T GottoFarhang Rabbani
Jan 12, 2005·The Journal of Urology·Naji J ToumaJoseph L Chin
Dec 1, 2009·Urologic Oncology·Jonathan C PicardThomas E Keane
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arif HussainChuanfa Guo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.